Diversifying Eligibility to Enhance Real-World Results

被引：0
|
作者：
Fayyaz, Fatima [1 ]
Carvajal, Richard D. [1 ]
Devoe, Craig E. [1 ,2 ]
机构：
[1] Northwell Hlth Canc Inst, Lake Suceess, NY USA
[2] Zuckerberg Canc Ctr, 450 Lakeville Rd, Lake Success, NY 11042 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 23期
关键词：
NIVOLUMAB PLUS IPILIMUMAB; MELANOMA PATIENTS; OPEN-LABEL; MULTICENTER; COMBINATION; TRIAL;
D O I：
10.1200/JCO.23.00836
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3895 / +
页数：5
相关论文
共 50 条
  • [41] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, L.
    Gaudio, C.
    Cicogna, F.
    Tota, C.
    Petronilli, V
    Mennuni, S.
    De Ruvo, E.
    Calo, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (18) : 5690 - 5700
  • [42] Real-world eligibility and cost-effectiveness analysis for empagliflozin in patients with heart failure
    Kim, E. S.
    Park, S. K.
    Youn, J. C.
    EUROPEAN HEART JOURNAL, 2022, 43 : 972 - 972
  • [43] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, Luca
    Ferrari, Ilaria
    Gaudio, Carlo
    Cicogna, Francesco
    Tota, Claudia
    Petronilli, Valentina
    Mennuni, Silvia
    Ruvo, Ermenegildo De
    Calo, Leonardo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [44] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, L.
    Cicogna, F.
    Tota, C.
    Petronilli, V.
    Mennuni, S.
    De Ruvo, E.
    Calo, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 42 - 43
  • [45] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, Luca
    Ferrari, Ilaria
    Gaudio, Carlo
    Cicogna, Francesco
    Tota, Claudia
    Petronilli, Valentina
    Mennuni, Silvia
    De Ruvo, Ermenegildo
    Calo, Leonardo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [46] Real-world Eligibility for Revascularization in Acute Stroke: A 12 Year Single Center Statistics
    Vanacker, Peter
    Lambrou, Dimitris
    Eskandari, Ashraf
    Michel, Patrik
    STROKE, 2016, 47
  • [47] Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea
    Kim, Eui-Soon
    Park, Sun-Kyeong
    Youn, Jong-Chan
    Lee, Hye Sun
    Lee, Hae-Young
    Cho, Hyun-Jai
    Choi, Jin-Oh
    Jeon, Eun-Seok
    Lee, Sang Eun
    Kim, Min-Seok
    Kim, Jae-Joong
    Hwang, Kyung-Kuk
    Cho, Myeong-Chan
    Chae, Shung Chull
    Kang, Seok-Min
    Park, Jin Joo
    Choi, Dong-Ju
    Yoo, Byung-Su
    Cho, Jae Yeong
    Kim, Kye Hun
    Oh, Byung-Hee
    Greenberg, Barry
    Baek, Sang Hong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (01)
  • [48] Real-World Eligibility and Cost-Effectiveness Analysis for Empagliflozin in Patients with Heart Failure
    Kim, E.
    Kim, K.
    Park, S.
    Youn, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S82 - S82
  • [49] Improving Diversity in Clinical Trials by Using Real-world Data to Define Eligibility Criteria
    Royce, Trevor J.
    Zhao, Yihua
    Ryals, Cleo A.
    JAMA ONCOLOGY, 2023, 9 (04) : 455 - 456
  • [50] Real-world trials to answer real-world questions
    Freemantle, N
    Blonde, L
    Bolinder, B
    Gerber, RA
    Hobbs, FDR
    Martinez, L
    Ross, S
    PHARMACOECONOMICS, 2005, 23 (08) : 747 - 754
12345